You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 2, August 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Quantitation of Fibrinolytic Activity in Venous and Prosthetic Arterial Grafts

James S. T. Yao, MD, PhD; John J. Bergan, MD; Hau C. Kwaan, MD

AMA Arch Surg. 1974;109(2):163-167.


Abstract

Fifty-six fresh specimens removed during vascular operations were examined histochemically to determine tissue fibrinolytic activity in the endothelium and adventitia. Prosthetic grafts, saphenous vein grafts, saphenous and varicose veins, and atheromatous femoropopliteal arteries were studied with the following results: (1) Normal vein walls (adventitia) were rich in plasminogen activator with minimal fibrinolytic activity in the endothelium. Fibrotic varicose veins showed reduced lysis activity in the adventitia. (2) There was no fibrinolytic activity in the neointima of all prosthetic materials, except where there was capillary loop formation. (3) Lysis was not present in any of the occluded saphenous vein grafts. (4) Fibrinolytic activity was reduced in atheromatous arteries, except in the area adjacent to fibrin plaques. We conclude that plasminogen activator is of vascular origin; that its activity is dynamic; and that absence of fibrinolytic activity may be an important contributing factor in graft failures.



Author Affiliations

From the departments of surgery (Drs. Yao and Bergan) and medicine (Dr. Kwaan), Northwestern University Medical School; the Hematological Research Laboratory, VA Research Hospital (Dr. Kwaan); and the Blood Flow Laboratory, Northwestern Memorial Hospital (Drs. Yao and Bergan), Chicago.


Footnotes

Accepted for publication April 2, 1974.

Read before the 31st annual meeting of the Central Surgical Association, Cincinnati, March 7, 1974.

Reprint requests to Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611 (Dr. Yao).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Plasminogen Activator Inhibitor-1 in Neointima of Vein Grafts : Its Role in Reduced Fibrinolytic Potential and Graft Failure
Kauhanen et al.
Circulation 1997;96:1783-1789.
ABSTRACT | FULL TEXT  

Thrombolysis and Stroke: Past and Future
Sloan
Arch Neurol 1987;44:748-768.
ABSTRACT  

Tissue Fibrinolytic Activity in Different Types of Varicose Veins
Hach et al.
ANGIOLOGY 1986;37:718-724.
ABSTRACT  

Efficacy of Low-Dose Streptokinase in Acute Arterial Occlusion and Graft Thrombosis
Kakkasseril et al.
Arch Surg 1985;120:427-429.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.